Transcatheter aortic valve replacement for patients in China
Official title: THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT02803294 · Data updated 2026-11-12
This study tests whether a heart valve replacement procedure called TAVR is safe and effective for people in China with serious heart valve problems.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hanzhou, Zhejiang) |
| Status | Recruiting |
| Started | June 2016 |
| Main results expected | July 2026 |
| Study ends | July 2027 |
| Registry record updated | July 15, 2021 |
| Trial ID | NCT02803294 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with symptomatic aortic stenosis or severe aortic regurgitation who meet specific technical and anatomical criteria for the procedure.
✕Probably not a fit
Patients with a life expectancy of less than one year or those with contraindications to the procedure will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and effectiveness of transcatheter aortic valve replacement (TAVR) specifically in the Chinese population suffering from symptomatic aortic stenosis or severe aortic regurgitation. Patients undergo thorough physical exams and screening tests to determine their eligibility for the procedure. Those who qualify will receive TAVR and will be monitored for outcomes related to the intervention. The study aims to gather data that could inform future treatment protocols for this demographic.
Why it matters
Potential benefit: If successful, this study could improve treatment options and outcomes for patients with symptomatic aortic stenosis in the Chinese population.
How similar studies have gone: Other studies have shown success with transcatheter aortic valve replacement, but this specific focus on the Chinese population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with symptomatic aortic stenosis/regurgitation * Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. * The subject agrees to comply with specified follow-up evaluations and to return to the investigational site where the procedure was performed. * Patients are technical and anatomical eligible for interventions Exclusion Criteria: * A known hypersensitivity or contraindication to any of the following which cannot be adequately pre-medicated: Aspirin Heparin (HIT/HITTS) and bivalirudin Nitinol (titanium or nickel) Ticlopidine and clopidogrel Contrast media * Subject refuses a blood transfusion. * Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the subject from appropriate consent. * Life expectancy is less than one year
Where it's running
-
The Second Affiliated Hospital, School of Medicine at Zhejiang University
Hanzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Jian-an Wang, MD,PhD — Second Affiliated Hospital of Zhejiang University School of Medicine
- Study coordinator: Xianbao Liu, MD
- Email: liuxb2009@hotmail.com
- Phone: +86-13857173887
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving decision-making for patients with aortic valve stenosis
This study tests if a new way of helping patients with severe aortic stenosis make treatment choices can improve their satisfaction and outcomes compared to standard care.
-
Evaluation of a new self-expanding aortic valve for severe aortic stenosis
This study is testing a new self-expanding heart valve to see if it is safe and effective for people with severe aortic stenosis.
-
Intelligent Video Laryngoscope to Help Emergency Intubations
A smart video laryngoscope with AI is tested to help doctors place tubes in critically ill adults needing emergency intubation.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Ultrasound-guided nasal bone fracture reduction
This study tests whether using ultrasound to guide nasal bone fracture reduction can improve accuracy and outcomes for people with recent nasal injuries.
-
Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage
This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.